Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer
Advanced Materials · 2025-09 · 37 (35)
DOI: 10.1002/adma.202502617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 17.06.2025. Verfasst von Dongdong Zheng und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Artesunate, Cancer-Associated Fibroblasts, Serine. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Joint Fund of the Zhejiang Provincial Natural Science Foundation of China, Discipline Cluster of Oncology, Wenzhou Medical University, China, Research Project.
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs) play a pivotal role in inducing photothermal therapy (PTT) resistance of triple‐negative breast cancer (TNBC), but with unclear mechanism. Herein, aminoethyl anisamide‐modified nano‐biomimetic low‐density lipoprotein (A‐aLDL) is used to target deliver the PTT agent and artesunate (ARS) to both CAFs and cancer cells. Though CAFs are sensitive to PTT and notably transition to heat‐resistant phenotype, the formed protective barrier is destroyed by ARS. Subsequently, the outstanding anti‐tumor effects are achieved through PTT in multiple models with such kind of combination therapy. Interestingly, the mechanism is discovered that serine metabolism plays a major role in CAF resistance through spatially omics. ARS disrupts serine homeostasis, thereby attenuating the cascade activity of GTPases in MAPK pathway. Meanwhile, MAP2K7 is the most potential target for sensitizing PTT. By integrating ARS with PTT agents, the serine‐MAPK axis in CAFs is successfully modulated, thereby overcoming PTT resistance in TNBC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.
- Joint Centre of Translational Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, P. R. China.
- Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku, FI-00520, Finland.
- Turku Bioscience Center, University of Turku and Åbo Akademi University, Turku, FI-00520, Finland.
- Institutes of Biomedical Sciences and Department of Chemistry, Fudan University, Shanghai, 200032, P. R. China.
ORCID-Profile: Dongdong Zheng, Hongbo Zhang
Förderung
- Joint Fund of the Zhejiang Provincial Natural Science Foundation of China
- Discipline Cluster of Oncology, Wenzhou Medical University, China
- Research Project
- Solution for Health Profile
- Research Council of Finland
- InFLAMES Flagship
- National Natural Science Foundation of China
- Shanghai Committee of Science and Technology
Zitieren
APA
Zheng, D., Yan, J., Liu, X., Zhang, Z., Jin, A., Zhao, Y., Bai, L., Quan, M., Qi, X., Fu, B., Wu, Z., Zhou, J., Han, H., Wang, Z., Wang, S., Deng, C., Sun, W., Chang, C., Zhou, S., & Zhang, H. (2025). Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer. Advanced Materials, 37(35). https://doi.org/10.1002/adma.202502617
Vancouver
Zheng D, Yan J, Liu X, Zhang Z, Jin A, Zhao Y, et al. Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer. Advanced Materials. 2025;37(35). doi:10.1002/adma.202502617
BibTeX
@article{Zheng2025,
author = {Zheng, Dongdong and Yan, Jiaqi and Liu, Xuejiao and Zhang, Zhiming and Jin, Anqi and Zhao, Yue and Bai, Lu and Quan, Mengyao and Qi, Xiuzhu and Fu, Bin and Wu, Zhigang and Zhou, Jin and Han, Han and Wang, Ziqi and Wang, Shiyu and Deng, Chaoqiang and Sun, Weijian and Chang, Cai and Zhou, Shichong and Zhang, Hongbo},
title = {Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {35},
doi = {10.1002/adma.202502617}
}
EUVIMED